|
13 Oct 2026 |
CCL Products
|
Consensus Share Price Target
|
1070.70 |
1346.36 |
- |
25.75 |
buy
|
|
|
|
|
29 Jul 2026
|
CCL Products
|
Axis Direct
|
1070.70
|
1425.00
|
1198.60
(-10.67%)
|
33.09 |
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
28 Jul 2026
|
CCL Products
|
IDBI Capital
|
1070.70
|
1142.00
|
1198.60
(-10.67%)
|
Target met |
Hold
|
|
|
CCL Products Q1FY27 performance remained mixed bag. Sales grew 14% YoY to Rs12bn, driven by 20% YoY volume growth which was offset by 6% YoY drop in NSR. Gross margin expanded by 252bps YoY to 35.2%, due to lower input costs and improved product mix. Consequently, EBITDA margin expanded by 106bps YoY to 16.1%, despite higher employee costs (24% YoY) and other overheads (23% YoY). PAT increased by 61% YoY to Rs1,169mn, aided by lower finance cost (-15% YoY) as net debt decreased by Rs...
|
|
14 May 2026
|
CCL Products
|
Keynote Capitals Ltd
|
1070.70
|
1269.00
|
1111.80
(-3.70%)
|
18.52 |
Buy
|
|
|
Quarterly Update Q4FY26
|
|
11 May 2026
|
CCL Products
|
Axis Direct
|
1070.70
|
1280.00
|
1099.20
(-2.59%)
|
19.55 |
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
11 May 2026
|
CCL Products
|
BP Wealth
|
1070.70
|
|
1099.20
(-2.59%)
|
|
Results Update
|
|
|
|
|
08 May 2026
|
CCL Products
|
IDBI Capital
|
1070.70
|
1139.00
|
1099.20
(-2.59%)
|
Target met |
Hold
|
|
|
CCL Products Q4FY26 performance exceeded our expectations. Sales grew 46% YoY to Rs12.2bn, driven by 18% YoY volume growth and 28% YoY increase in realization led by favorable coffee prices. Gross margin contracted by 920bps YoY to 35.1%, due to higher input costs and change in product mix. Consequently, EBITDA margin contracted by 387bps YoY to 15.7%, despite lower employee costs (-128bps YoY) and other overheads (-405bps YoY). PAT increased by 12% YoY to Rs1,145mn, impacted by higher depreciation (+50% YoY) and lower other income (-50% YoY). Capacity utilisation stood at 65% in...
|
|
01 Apr 2026
|
CCL Products
|
Geojit BNP Paribas
|
1070.70
|
1350.00
|
1082.30
(-1.07%)
|
26.09 |
Buy
|
|
|
CCL Products (India) Ltd., established in 1994, is a leading global coffee manufacturer and exporter with operations across India and a presence in over 100 countries. Its diversified product portfolio includes spray-dried and freeze-dried coffee, liquid concentrates, roast and ground coffee, coffee beans, and premixed blends. The company's international footprint is supported by key subsidiaries,...
|
|
10 Feb 2026
|
CCL Products
|
Keynote Capitals Ltd
|
1070.70
|
1298.00
|
1031.05
(3.85%)
|
21.23 |
Buy
|
|
|
Quarterly Update Q3FY26
|
|
06 Feb 2026
|
CCL Products
|
IDBI Capital
|
1070.70
|
1077.00
|
990.55
(8.09%)
|
Target met |
Hold
|
|
|
CCL Products Q3FY26 performance was above our expectations. Sales grew 38% YoY to Rs10.5bn, driven by 20% YoY volume growth and 18% YoY increase in realization due to improved coffee blends and stable raw material prices. Gross margin contracted by 308bps YoY to 37.1%, primarily due to higher input costs. However, EBITDA margin expanded by 120bps YoY to 17.6%, driven by improved product mix as freeze-dried plant at Vietnam has started ramping up. PAT increased by 59% YoY to Rs1,003mn. CCL has revised EBITDA growth guidance to 25% (previously 15%-20%), with volume growth of 18% for FY26....
|
|
06 Feb 2026
|
CCL Products
|
Axis Direct
|
1070.70
|
1140.00
|
990.55
(8.09%)
|
Target met |
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
05 Feb 2026
|
CCL Products
|
BP Wealth
|
1070.70
|
|
990.00
(8.15%)
|
|
Results Update
|
|
|
|
|
10 Nov 2025
|
CCL Products
|
Keynote Capitals Ltd
|
1070.70
|
1284.00
|
1068.45
(0.21%)
|
19.92 |
Buy
|
|
|
Quarterly Update Q2FY26
|
|
07 Nov 2025
|
CCL Products
|
IDBI Capital
|
1070.70
|
932.00
|
1025.15
(4.44%)
|
Target met |
Hold
|
|
|
CCL Products Q2FY26 performance was above our expectations. Sales grew 53% YoY to Rs11.3bn, driven by 20+% YoY volume growth and 33% YoY increase in realization due to improved coffee blends and higher prices. Gross margin contracted by 524bps YoY to 34.5%, primarily due to higher input costs. Consequently, EBITDA margin contracted by 107bps YoY to 17.5%, despite operational efficiencies and a favorable product mix. PAT increased by 36% YoY to Rs1,009mn. CCL maintained its volume and EBITDA growth guidance of 1020% and 15-20%, respectively and expects to close FY26 toward the upper end of this range. We value the stock at a PER of 25x FY27E EPS, arriving at a target...
|
|
07 Nov 2025
|
CCL Products
|
Axis Direct
|
1070.70
|
1140.00
|
1025.15
(4.44%)
|
Target met |
Buy
|
|
|
With a 17% upside from the CMP, we maintain our BUY rating on the stock.
|
|
08 Aug 2025
|
CCL Products
|
Keynote Capitals Ltd
|
1070.70
|
1203.00
|
864.35
(23.87%)
|
Target met |
Buy
|
|
|
Quarterly Update Q1FY26
|
|
07 Aug 2025
|
CCL Products
|
Axis Direct
|
1070.70
|
970.00
|
862.65
(24.12%)
|
Target met |
Buy
|
|
|
With a 12% upside from the CMP, we maintain our BUY rating on the stock.
|
|
07 Aug 2025
|
CCL Products
|
IDBI Capital
|
1070.70
|
849.00
|
862.65
(24.12%)
|
Target met |
Hold
|
|
|
CCL Products Q1FY26 profitability was below our expectations. Sales grew 37% YoY to Rs10.7bn, driven by 9-10% YoY volume growth and 27-28% YoY increase in realization due to improved coffee blends. Gross margin contracted by 543bps YoY to 32.6%, driven by higher input cost. Consequently, EBITDA margin contracted by 178bps YoY to 15.1%. EBITDA grew 22% YoY to Rs1.6bn, driven by a favorable product mix in B2B and growth in the B2C category. PAT increased by 1% YoY to Rs724mn. CCL maintained its volume and EBITDA growth guidance of 10-20% and 15-20%, respectively. Management expects some price...
|
|
07 May 2025
|
CCL Products
|
Axis Direct
|
1070.70
|
800.00
|
772.60
(38.58%)
|
Target met |
Buy
|
|
|
With a 15% upside from the CMP, we maintain our BUY rating on the stock
|
|
07 May 2025
|
CCL Products
|
Keynote Capitals Ltd
|
1070.70
|
1126.00
|
772.60
(38.58%)
|
Target met |
Buy
|
|
|
Quarterly Update Q4FY25
|
|
06 May 2025
|
CCL Products
|
IDBI Capital
|
1070.70
|
738.00
|
772.60
(38.58%)
|
Target met |
Hold
|
|
|
|